Clinical Trials Logo
  1. Home
  2. Brain Infarction
  3. NCT04270513

Flying Intervention Team for Endovascular Treatment of Acute Ischemic Stroke in Rural Areas — FIT  

Brain Infarction Clinical Trial

Official title:
Flying Intervention Team for Endovascular Treatment of Acute Ischemic Stroke in Rural Areas

Clinical Trial Summary

The aim of this study is to compare time delay and safety parameters of stroke patients initially admitted to a rural primary stroke center (PSC) who receive endovascular treatment (EVT) by a Flying Intervention Team with patients who receive EVT after secondary transfer to a comprehensive stroke center (CSC).

Clinical Trial Description

A novel health care concept was implemented in the telemedical stroke network TEMPiS (Telemedical Project for integrative Stroke Care) to reduce time delays to EVT in stroke patients with large vessel occlusion: After telemedicine-assisted identification of EVT candidates in a PSC, a Flying Intervention Team (neuroradiologist and angiography assistant) is flown from a CSC via helicopter to the PSC to perform EVT in the local angiography suite. Flying Intervention Team service runs from 8 a.m. to 10 p.m. Patients remain at local stroke unit for further treatment.

Analysis will include time delay to EVT, recanalization, symptomatic intracerebral hemorrhage, periprocedural complications, in-hospital complications, and mortality. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04270513
Study type Observational [Patient Registry]
Source Munich Municipal Hospital
Contact
Status Active, not recruiting
Phase
Start date February 1, 2018
Completion date April 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT01977456 - Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR) Phase 2
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT01561677 - Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke. N/A
Terminated NCT00141011 - Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Phase 3
Completed NCT02684825 - Detection of Silent Atrial Fibrillation aFter Ischemic StrOke N/A
Completed NCT00829361 - Stroke Telemedicine for Arizona Rural Residents Trial N/A
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT01934725 - Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome
Terminated NCT01059149 - Safety and Long-term Effectiveness of High Frequency Repetitive Transcranial Magnetic Stimulation of Stroke (RAICup) Phase 2
Recruiting NCT05068349 - For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide. Phase 4
Completed NCT05086874 - Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients
Completed NCT00126516 - Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline Phase 4
Completed NCT02389894 - Neuroprotection in Patients Undergoing Aortic Valve Replacement N/A
Terminated NCT00300196 - ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke Phase 3
Completed NCT00871715 - Arm Rehabilitation Study After Stroke N/A
Completed NCT04265664 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke N/A
Completed NCT04043559 - Cortical Cerebellar Infarctions Associated With Patent Foramen Ovale in Young Stroke Patients
Completed NCT00894803 - Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke Phase 2
Active, not recruiting NCT00657969 - Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections N/A
Completed NCT05169450 - Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke N/A